Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
about
Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanomaDrug-induced respiratory disorders: incidence, prevention and management.Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease.Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications.Fatal pulmonary toxic effects of lomustineCardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors.Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.Effects of high-dose chemotherapy with syngeneic bone marrow transplantation in experimental brain tumor in rats.BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.Fatal pneumothorax in "BCNU lung".Sequential pathological changes induced in rats with the anti-cancer drug I, 3-bis (2-chloroethyl)-I-nitrosourea (BCNU).Intensive chemotherapy with autologous bone marrow rescue for recurrent malignant gliomas.Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies
P2860
Q33494887-A0894437-711B-4382-A484-93014336554DQ34005812-A88DD31A-E2A8-4B85-B3DF-6CE260C322BFQ36036173-2614F0B0-4115-42B3-9371-9FB5DB9BF30BQ36420106-2D8F97E9-88FE-4F2A-A368-6A1D3DC43843Q38577335-74DFF184-A4BF-437C-93C1-8C77E06ED97BQ40153175-2339CDA9-7457-4232-8002-39CC05FDD15AQ41119429-B4C04FA5-4C77-4319-9A27-F4D79BE4B3E9Q43901285-723F0086-AEAA-431A-BDA6-FEE3158B19F0Q44442090-3ED3447E-AFA2-421B-8FA2-4768386F111BQ44639979-9BDE9772-E49C-4421-93FB-8EAD21E194AEQ46141236-D2096AB2-FBF8-4B04-8B09-13C1DC462196Q48346225-9732F2F1-0C29-4923-A4C6-BBCCE82F5D3DQ48634052-2AF13DBC-4D96-4A85-AA07-A784AED35F78Q49058159-16AC2385-4987-4D70-8FD9-14A0A6B1C6D9Q54449235-50FA697D-ADB1-4A6C-93E0-CC95BE63D09FQ55489001-27BA51C2-B601-4B7D-9475-C70E0A01AE4BQ57786613-6C6DE21A-D9E3-46FD-96A5-588CFDDBF07A
P2860
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
@en
type
label
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
@en
prefLabel
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
@en
P2093
P1476
Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
@en
P2093
A A Bartolucci
J R Durant
K H Langford
M J Norgard
P304
P356
10.7326/0003-4819-90-2-191
P407
P577
1979-02-01T00:00:00Z